SOFI vs SYRE · P/E 39, rev $283.1M vs $7.60B cap
SoFi Technologies Inc. (SOFI) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ. It is led by Anthony J. Noto.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
SOFI currently screens at market cap $22.25B and trailing P/E 38.5. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the SOFI and SYRE stock pages for the full models.
Not investment advice.